STATEMENT OF CASH FLOWS	7 Months Ended
	Sep. 30, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (62,219)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on marketable securities (net), dividends and interest, held in Trust Account	(537)
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(214,818)
Accounts payable and accrued expenses	108,766
Net cash used in operating activities	(168,808)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(201,000,000)
Net cash used in investing activities	(201,000,000)
Cash Flows from Financing Activities:
Advances from related party	250,000
Repayment of note payable and advances from related party	(250,000)
Proceeds from issuance of common stock to Sponsor	33,333
Proceeds from sale of Class A common stock, net of transaction costs	195,308,710
Proceeds from sale of Private Placement Warrants	7,375,000
Net cash provided by financing activities	202,717,043
Net increase in cash	1,548,235
Cash - end of period	1,548,235
Supplemental disclosure of noncash investing and financing activities:
Deferred underwriting and advisory fees payable	9,000,000
Initial classification of common stock subject to possible redemption	200,000,000
Remeasurement adjustment on redeemable common stock	22,855,181
Excess of fair value of founder shares offered to the anchor investors	$ 8,163,891